scispace - formally typeset
H

Hatem H. Salem

Researcher at Monash University

Publications -  101
Citations -  5682

Hatem H. Salem is an academic researcher from Monash University. The author has contributed to research in topics: Protein C & Platelet. The author has an hindex of 39, co-authored 101 publications receiving 5432 citations. Previous affiliations of Hatem H. Salem include Washington University in St. Louis & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis.

TL;DR: Vitamin K1 should be given in a dose that will quickly lower the INR to a safe, but not subtherapeutic, range and will not cause resistance once warfarin is reinstated.
Journal Article

Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester.

TL;DR: Data show that APC inhibits host cytokine production but maintains MO responses associated with adhesion, phagocytosis, and killing of Gram-negative bacteria, such that use of APC may be a logical and potent adjunctive therapy in select inflammatory diseases involving MO activation and damagingHost cytokine overproduction.
Journal ArticleDOI

Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function

TL;DR: 2 distinct pathways regulating the procoagulant function of platelets are shown, one of which is Bak/Bax- and caspase-dependent and the other is agonist-induced, which was completely eliminated by extracellular calcium chelators or inhibitors of platelet activation.
Journal ArticleDOI

Intradermal Influenza Vaccine Administered Using a New Microinjection System Produces Superior Immunogenicity in Elderly Adults: A Randomized Controlled Trial

TL;DR: For the first time, the intradermal vaccination route has been used to elicit immune responses significantly superior to those noted in association with the conventional intramuscular vaccination route, expected to enhance annual protection against influenza in this vulnerable population.